Some Insurers Make Access To Bariatric Surgery Easier Than Weight Loss DrugsBy Press Room3 April 2024 Amid increased concern about the costs of using glucagon-like peptide 1 agonists to treat obesity, some insurers are imposing further…
Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit UptakeBy Press Room2 April 2024 The Food and Drug Administration approved Winrevair last week. The drug is indicated for a rare and deadly cardiovascular disorder…
House Of Representatives Passes Bill To Ban Use Of QALYs In Federally Funded Healthcare ProgramsBy Press Room9 February 2024 The U.S. House of Representatives passed H.R. 485, the Protecting Health Care for All Patients Act, this week. The bill…
Passage Of Treat And Reduce Obesity Act Faces An Uphill BattleBy Press Room4 January 2024 A push to lift Medicare’s prohibition on coverage of weight loss drugs is picking up steam in Congress. The history…